Item 2.02. Results of Operations and Financial Condition.

On August 4, 2020, Kaleido Biosciences, Inc. (the "Company") announced its financial results for the second quarter ended June 30, 2020. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Form 8-K (including Exhibits 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits:



Exhibit No.   Description

                Press Release issued by Kaleido Biosciences, Inc., dated August 4, 2020,
99.1          furnished herewith
              Cover Page Interactive Data File (embedded within the Inline XBRL
104           document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses